Reply:

References

1. 1.↵
   2. Tomsick T

   . TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28:382–84 pmid:17297017

   FREE Full Text
2. 2.↵
   2. Broderick JP,
   3. Palesch YY,
   4. Demchuk AM, et al

   . Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893–903 doi:10.1056/NEJMoa1214300 pmid:23390923

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Zaidat OO,
   3. Yoo AJ,
   4. Khatri P, et al

   . Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650–63 doi:10.1161/STROKEAHA.113.001972 pmid:23920012

   FREE Full Text
4. 4.↵
   2. Tomsick TA,
   3. Yeatts SD,
   4. Liebeskind DS, et al

   . Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. J Neurointerv Surg 2015;7:795–802 doi:10.1136/neurintsurg-2014-011318 pmid:25342652

   Abstract/FREE Full Text
5. 5.↵
   2. Tomsick TA,
   3. Foster LD,
   4. Liebeskind DS, et al

   . Outcome differences between intra-arterial iso- and low-osmolality iodinated radiographic contrast media in the Interventional Management of Stroke III trial. AJNR Am J Neuroradiol 2015;36:2074–81 doi:10.3174/ajnr.A4421 pmid:26228892

   Abstract/FREE Full Text
6. 6.↵
   2. Fischer E

   . Die Lageabweichungen der vorderen Hirnarterie im Gefäßbild. Zentralbl Neurochir 1938;3:300–13
7. 7.↵
   2. Goyal M,
   3. Menon BK,
   4. Krings T, et al

   . What constitutes the M1 segment of the middle cerebral artery? J Neurointerv Surg 2016 Jan 11. [Epub ahead of print] doi:10.1136/neurintsurg-2015-012191 pmid:26863104

   Abstract/FREE Full Text
8. 8.↵
   EMS Study Group. Emergency management of stroke: IV placebo vs. IV t-PA plus intra-arterial t-PA in stroke treatment. In: Proceedings of the 21st International Conference on Stroke and Cerebrovascular Disease, San Antonio, Texas. January 24, 1996
9. 9.↵
   2. Lewandowski CA,
   3. Frankel M,
   4. Tomsick TA, et al

   . Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–605 doi:10.1161/01.str.30.12.2598 pmid:10582984

   Abstract/FREE Full Text
10. 10.↵
    The IMS Writing Group. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904–11 doi:10.1161/01.STR.0000121641.77121.98 pmid:15017018

    Abstract/FREE Full Text
11. 11.↵
    The IMS II Trial Investigators. The Interventional Management of Stroke (IMS) Study. Stroke 2007;38:2127–35 doi:10.1161/STROKEAHA.107.483131 pmid:17525387

    Abstract/FREE Full Text
12. 12.↵
    2. del Zoppo GJ,
    3. Higashida RT,
    4. Furlan AJ, et al

    . Prolyse in acute cerebral thromboembolism trial (PROACT): results of 6 mf dose tier. In: Proceedings of the 21st International Conference on Stroke and Cerebrovascular Disease, San Antonio, Texas. January 24, 1996
13. 13.↵
    2. Furlan A,
    3. Higashida R,
    4. Wechsler L, et al

    . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11 doi:10.1001/jama.282.21.2003 pmid:10591382

    CrossRefPubMedWeb of Science